| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
George Simeon is a Director, 10% Owner at Design Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 12 buys and 0 sells.
Estimated insider holdings value: $109.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2025 | CRSP Crispr Therapeutics AG | Director | Buy | 989,812 | $52.03 | $51,499,918.36 | +94.4% | +25.8% | - | |
| Mar 27, 2024 | NKTX Nkarta, Inc. | Director | Buy | 2,000,000 | $10.00 | $20,000,000.00 | New | -44.7% | -82.2% | |
| Dec 20, 2022 | DSGN Design Therapeutics, Inc. | Director, 10% Owner | Buy | 900,000 | $8.42 | $7,574,078.00 | +4.9% | -19.1% | -68.1% | |
| Apr 28, 2022 | NKTX Nkarta, Inc. | Director | Buy | 1,333,333 | $15.00 | $19,999,995.00 | New | -28.7% | -72.5% | |
| Mar 30, 2021 | DSGN Design Therapeutics, Inc. | Director, 10% Owner | Buy | 250,000 | $20.00 | $5,000,000.00 | +4.6% | -22.5% | -45.8% | |
| Oct 24, 2016 | CRSP Crispr Therapeutics AG | Director | Buy | 66,500 | $14.00 | $931,000.00 | +2.1% | - | - |